- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Navicixizumab Combo Shows Benefit in Heavily Pretreated Ovarian Cancer
April 3rd 2020, 1:59am
The anti-DLL4/VEGF bispecific antibody navicixizumab showed promising clinical activity when used in combination with paclitaxel in heavily pretreated patients with platinum-resistant ovarian cancer.
Frontline Maintenance Vigil Immunotherapy Improves RFS in Ovarian Cancer
April 3rd 2020, 12:38am
Frontline maintenance treatment with Vigil immunotherapy demonstrated an improvement in relapse-free survival compared with placebo in patients with stage III/IV ovarian cancer, especially in those with BRCA1/2 wild-type disease.
Dr. Swisher on How the VELIA Trial Stands Out in Ovarian Cancer Research
April 2nd 2020, 10:50pm
Elizabeth M. Swisher, MD, discusses how the phase III VELIA/GOG-3005 trial compares with other trials examining up-front maintenance therapy in ovarian cancer.
Veliparib Improves PFS in BRCA Wild-Type Ovarian Cancer, Regardless of HRD Status
April 2nd 2020, 6:53pm
Veliparib plus chemotherapy extended progression-free survival for BRCA wild-type patients with high-grade serous carcinoma.
Dr. Shah on the Role of Immunotherapy in Gastroesophageal Cancer
March 21st 2020, 2:36am
School of Gastrointestinal Oncology
Manish A. Shah, MD, discusses the role of immunotherapy in gastroesophageal cancer.
Dr. Choti on the Benefits of Neoadjuvant Chemotherapy in Pancreatic Cancer
March 21st 2020, 2:23am
School of Gastrointestinal Oncology
Michael A. Choti, MD, discusses the benefit of neoadjuvant chemotherapy in pancreatic cancer.
Dr. Marshall on Challenges in CRC Treatment
March 21st 2020, 2:17am
School of Gastrointestinal Oncology
John L. Marshall, MD, discusses the challenges in the colorectal cancer field.
Immunotherapy Combinations Are King in Frontline RCC Treatment
March 14th 2020, 1:33am
In metastatic renal cell carcinoma, the use of frontline combination immunotherapy regimens has led to significant survival benefits for patients, and efforts are now being focused on exploring novel options for those who become refractory to this approach.
Dr. Gomella on the State of Genetic Testing and Screening in Prostate Cancer
March 14th 2020, 12:37am
Leonard G. Gomella, MD, professor, chair, Department of Urology, and director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses the state of genetic testing in prostate cancer.
Gomella Offers Guidance on Screening, Genetic Testing in Prostate Cancer
March 14th 2020, 12:07am
Leonard G. Gomella, MD, discusses the state of genetic testing in prostate cancer, shares his recommendations for screening, and provides perspective on where the field is headed.
Dr. Petrylak on Available Treatment Options in Metastatic Bladder Cancer
March 13th 2020, 11:47pm
Daniel P. Petrylak, MD, discusses available treatment options in metastatic bladder cancer.
Further Study Is Needed to Maximize Therapeutic Benefit in Urothelial Cancer
March 13th 2020, 11:33pm
In metastatic urothelial cancer, the portfolio of immunologic therapies is robust, but the treatment paradigm for these agents requires refinement.
Burnout in Doctors and Mitigation Strategies
March 10th 2020, 8:12pm
PER® Miami Breast Cancer Conference
What may have worked before to mitigate burnout may no longer work now because we change, and so do our work environments.
Navigating Treatment Options for Patients With Early-Stage Breast Cancer
March 10th 2020, 5:40pm
PER® Miami Breast Cancer Conference
Genetic advances have helped elucidate the heterogenous nature of breast cancer, however optimal strategies for patients with early-stage disease still need to be ironed out.
Survivorship Starts at Diagnosis in Breast Cancer
March 10th 2020, 12:13am
PER® Miami Breast Cancer Conference
The inclusion of patients from the time of diagnosis and encompassing family, friends, and caregivers is central to moving survivorship care forward, especially for breast cancer survivorship, which has high survival rates for early disease and the emergence of novel treatments for advanced cancers.
Dr. O'Shaughnessy on the Utility of Capivasertib in Targeting Akt in Breast Cancer
March 9th 2020, 12:01am
PER® Miami Breast Cancer Conference
Joyce A. O'Shaughnessy, MD, discusses the utility of targeting capivasertib in targeting Akt mutations in breast cancer.
Dr. Tripathy on Personalized Therapy Options in Metastatic Breast Cancer
March 8th 2020, 11:50pm
PER® Miami Breast Cancer Conference
Debu Tripathy, MD, discusses personalized therapy options in metastatic breast cancer.
Gottlieb Addresses Coronavirus, Innovation in Keynote Address
March 8th 2020, 7:26pm
PER® Miami Breast Cancer Conference
The novel coronavirus spreading across the world represents a distinct challenge for all physicians, especially oncologists who commonly treat patients who have compromised immune systems.
Exercise Programs Improve Outcomes for Patients With Breast Cancer
March 8th 2020, 7:12pm
PER® Miami Breast Cancer Conference
Special attention to reducing the risk of cardiovascular disease should be a priority for long-term care of patients with breast cancer.
Dr. Borgen on the De-Escalation of Surgery in Breast Cancer
March 8th 2020, 5:12am
PER® Miami Breast Cancer Conference
Patrick I. Borgen, MD, discusses the trend toward surgical de-escalation in patients with breast cancer.